Effectiveness and safety of dupilumab in adults with moderate-to-severe atopic dermatitis previously treated with JAK inhibitors. Bernardo D, Alvarenga JM, Torres T. Eur J Dermatol 2025;35:64-65.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bernardo D, Alvarenga JM, Torres T. Effectiveness and safety of dupilumab in adults with moderate-to-severe atopic dermatitis previously treated with JAK inhibitors. Eur J Dermatol 2025;35:64-65.
PMID: 40110833